6:28 PM
 | 
Nov 13, 2012
 |  BC Extra  |  Company News

Alnylam, Tekmira restructure partnership, settle litigation

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and Tekmira Pharmaceuticals Corp. (TSX:TKM; NASDAQ:TKMR) agreed to a new deal that will settle all litigation between the partners, including a suit related to Tekmira's lipid nanoparticle (LNP) siRNA delivery technology. Alnylam will pay Tekmira $65 million, including $35 million to terminate the partners' prior deals and to reduce milestone...

Read the full 259 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >